| Date Filed | Type | Description |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Bought 5 shares
@ $69.3091, valued at
$346.5 |
|
| 12/09/2020 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Bought 5 shares
@ $66.248, valued at
$331.2 |
|
| 11/23/2020 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on Galecto, Inc.|
Txns:
| Granted 18,000 options to buy
@ $16.6, valued at
$298.8k
Granted 9,000 options to buy
@ $16.6, valued at
$149.4k
|
|
| 11/23/2020 |
3
| Dallas Jayson Donald Alexander (Director) has filed a Form 3 on Galecto, Inc. |
| 10/14/2020 |
4
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Unknown transaction of 30,422 shares
@ $34.5, valued at
$1M
Disposed/sold 89,250 shares
@ $34.5, valued at
$3.1M
Disposed/sold 350,000 options to buy
@ $30.68, valued at
$10.7M
Disposed/sold 210,000 options to buy
@ $23.72, valued at
$5M
Disposed/sold 200,000 options to buy
@ $23.81, valued at
$4.8M
|
|
| 09/16/2020 |
4
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,642 shares
@ $34.25, valued at
$56.2k
|
|
| 06/26/2020 |
4
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,907 shares
@ $18.02, valued at
$142.5k
|
|
| 06/16/2020 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,446 shares
@ $0
Granted 5,000 options to buy
@ $61.31, valued at
$306.6k
|
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,654 shares
@ $0
Sold 1,355 shares
@ $55.8184, valued at
$75.6k
Sold 170 shares
@ $56.5082, valued at
$9.6k
Granted 5,000 options to buy
@ $56.5, valued at
$282.5k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2018 |
4
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Bought 3,600 shares
@ $27.558, valued at
$99.2k
Bought 50 shares
@ $27.5599, valued at
$1.4k
|
|
| 06/19/2018 |
4
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 60,000 shares
@ $0
Granted 350,000 options to buy
@ $30.68, valued at
$10.7M
|
|
| 06/19/2018 |
3
| Dallas Jayson Donald Alexander (President and CEO) has filed a Form 3 on Aimmune Therapeutics, Inc. |
| 06/15/2018 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 3,050 shares
@ $0
Granted 5,000 options to buy
@ $49.17, valued at
$245.9k
|
|
| 06/04/2018 |
4
| Dallas Jayson Donald Alexander (EVP & Chief Commercial Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 294 shares
@ $73.73, valued at
$21.7k
|
|
| 04/19/2018 |
4
| Dallas Jayson Donald Alexander (EVP & Chief Commercial Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,431 shares
@ $0 |
|
| 03/05/2018 |
4
| Dallas Jayson Donald Alexander (EVP & Chief Commercial Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 6,500 shares
@ $0
Paid exercise price by delivering 441 shares
@ $48.43, valued at
$21.4k
Granted 32,000 options to buy
@ $48.43, valued at
$1.5M
|
|
| 08/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/08/2016 |
4
| Dallas Jayson Donald Alexander (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 940 shares
@ $64.24, valued at
$60.4k
|
|
|